Literature DB >> 6428330

The effect of 2 mg estradiol-17 beta plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17 beta, progesterone, testosterone and prolactin after ovariectomy.

P Kemeter, G Bernaschek, G Altmann, W Feichtinger.   

Abstract

The object of the study was to see whether maintenance of serum estradiol levels corresponding to the early and mid-follicular phase can prevent the gonadotrophin increase following ovariectomy. We also wanted to study the effect on LH and FSH of an additional dose of 1 mg dose of 1 mg norethisterone acetate administered for 10 days during each month. In 22 women with normal cycles 1 mg of estradiol benzoate was injected i.m. at the time of ovariectomy. From the first post-operative day onwards they received daily doses of 2 mg estradiol and 1 mg estriol in the form of micronized tablets. From the 41st to the 50th day and again from the 69th to the 78th day the patients received additional daily doses of 1 mg norethisterone acetate. LH, FSH, estradiol-17 beta, (E2) progesterone (P), testosterone (T), and prolactin (PRL) were measured in intervals of 2-17 days. Even though the estradiol mean values remained constant in the range of 65-115 pg throughout the period under observation, the LH mean levels increased continuously from 8 to a maximum of 23.9 mU/ml, and the FSH mean level from a pre-operative value of 6-48.0 mU/ml on the 85th day. On the 7th day after the last administration of norethisterone acetate LH was slightly depressed while FSH continued to rise slightly. Both FSH and LH are negatively correlated with E2 and this inverse correlation becomes even more pronounced the more time has elapsed after surgery. These findings suggest that not only the estrogens inhibit FSH and LH but also other steroids and/or nonsteroidal ovarian inhibiting factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428330     DOI: 10.1007/bf00570759

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  17 in total

1.  DUAL ENDOCRINE ACTIVITY OF THE TESTES.

Authors:  D R McCullagh
Journal:  Science       Date:  1932-07-01       Impact factor: 47.728

2.  Evidence for inhibin-like activity in bovine follicular fluid.

Authors:  F H De Jong; R M Sharpe
Journal:  Nature       Date:  1976-09-02       Impact factor: 49.962

3.  An analysis of the negative feedback control of gonadotropin secretion utilizing chronic implantation of ovarian steroids in ovariectomized rhesus monkeys.

Authors:  F J Karsch; R F Weick; J Hotchkiss; D J Dierschke; E Knobil
Journal:  Endocrinology       Date:  1973-08       Impact factor: 4.736

4.  Progestogen-induced luteinizing and follicle-stimulating hormone surge in postmenopausal women: a simulated ovulatory peak.

Authors:  W D Odell; R S Swerdloff
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

5.  [Endocrine control of the menstrual cycle].

Authors:  L Wildt; G Leyendecker
Journal:  Gynakologe       Date:  1981-06

6.  The effects of human follicular fluid inhibin on the morphology of the ovary of the immature rat.

Authors:  S Chari; G Aumüller; E Daume; G Sturm; C Hopkinson
Journal:  Arch Gynecol       Date:  1981

7.  [Cyclic treatment of climacteric disorders with genuine estrogens].

Authors:  W Bartl; P Kemeter; F Friedrich; A Seidl
Journal:  Gynakol Rundsch       Date:  1982

8.  [Effects of clomiphene and estrogens on circulating gonadotropins, testosterone, androstenedione, in old menopausal women (author's transl)].

Authors:  M Pugeat; M G Forest; E de Peretti; J Tourniaire; J Bertrand
Journal:  Ann Endocrinol (Paris)       Date:  1977       Impact factor: 2.478

9.  Physiologic estradiol replacement following oophorectomy: failure to maintain precastration gonadotropin levels.

Authors:  J A Simon; G S diZerega
Journal:  Obstet Gynecol       Date:  1982-04       Impact factor: 7.661

10.  Purification of "inhibin" from human ovarian follicular fluid.

Authors:  S Chari; C R Hopkinson; E Daume; G Sturm
Journal:  Acta Endocrinol (Copenh)       Date:  1979-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.